慢性萎缩性胃炎的临床检测与治疗方法研究

Clinical Examination and Treatment Investigation Ofchronic Atrophic Gastritis

目的分析慢性萎缩性胃炎的临床治疗方法,推荐最佳用药方案,方法本研究中以 2 0 1 4年 1 月-2 0 1 6年 1 月为 观察时间段,收集该时间段内本院住院部的确诊慢性萎缩性胃炎患者作为研究对象,共 6 8例 .对病例进行随机分组,观察 组、对照组分别纳入 34例患者.观察组用药方案为果胶铋联合阿莫西林,对照组用药方案为果胶铋联合克拉霉素对比两组 患者在临床疗效方面的差异情况.结果 观察组患者临床治疗总有效率为 94. 12%（32/34）,对照组为 67. 65%（23/34）,观察 组显著高于对照组（ P〈0. 05）,差异显著且具有统计学意义.结论用果胶铋联合阿莫西林治疗慢性萎缩性胃炎的临床疗效 确切,较常规用药克拉霉素联合果胶铋价值更高,有推广价值.

Objective To analyze the clinical treatment of chronic atrophic gastritis, and to recommend the best medica-tion program. Methods In this study, the observation window started from January 2014 to January 2016. During this period, patients diagnosed as chronic atrophic gastritis who were admitted to inpatient department of our hospital were recruited as the research subjects？ a total of 68 cases were enrolled. The patients were randomly divided into observation group and control group, each group included 34 patients. The observation group was treated with pectin bismuth combined with amoxicillin, and the control group was given pectin bismuth combined with clarithromycin, the clinical efficacy was compared between the two groups. The total effective rate was 94. 12 % （32/34） in the observation group and 67.65% （23/34） in the controlgroup, the observation group was significantly higher than the control group （P〈0 . 05） , and the difference was statistically significant. Conclusion Pectin bismuth combined with amoxicillin proves more significant clinical efficacy in the treatment of chronic atrophic gastritis, which is better than the conventional drug clarithromycin combined with pectin bismuth and worthy of promotion.